XML 43 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Equity [Abstract]  
Summary of Allocated Stock-based Compensation Expense

The Company’s stock-based compensation expense is allocated between research and development and selling, general and administrative as follows:

 

     Three months ended,      Nine months ended,  

Stock-based compensation expense

   September 30,
2017
     September 30,
2016
     September 30,
2017
     September 30,
2016
 

Research and Development

   $ 0.5              $ 0.5              $ 1.3              $ 2.1          

Selling, General and Administrative

   $ 3.7              $ 3.6              $ 8.9              $ 9.5          
Weighted Average for Key Assumptions Used in Determining Fair Value of Options Granted

The weighted average for key assumptions used in determining the fair value of options granted during the nine months ended September 30, 2017 follows:

 

Expected price volatility

   78.68% -78.77%

Risk-free interest rate

   1.77% -1.87%

Weighted average expected life in years

   6 years

Dividend yield

   —  
Summary of Stock Option Activity

Option activity during the nine months ended September 30, 2017 was as follows:

 

     Number of
Shares
    Weighted
Average
Exercise
Price
Per Share
     Aggregate
Intrinsic
Value
 

Outstanding at January 1, 2017

     3,468,991     $ 4.14     

Granted in 2017

       

Officers and Directors

     83,658       2.64     

Others

     825,003       1.91     

Exercised

     (151,373     2.07     

Forfeitures

     (1,183,795     5.89     
  

 

 

   

 

 

    

Outstanding at September 30, 2017

     3,042,484     $ 2.92      $ 1,466  
  

 

 

   

 

 

    

 

 

 
Summary of Restricted Stock Activity
     Number of
Restricted
Shares
     Weighted
Average Fair
Market Value
Per RSU
 

Outstanding at January 1, 2017

     4,584,297      $ 7.29  

Granted:

     

Executive officers

     1,640,000        1.80  

Directors

     162,315        2.80  

Employees

     540,000        2.04  

Vested

     (1,568,042      2.17  

Forfeitures

     (554,675      2.28  
  

 

 

    

 

 

 

Outstanding at September 30, 2017

     4,803,895      $ 5.14  
  

 

 

    

 

 

 
Weighted Average for Key Assumptions Used in Determining Fair Value of Warrants Granted

The weighted average for key assumptions used in determining the fair value of warrants granted during the nine months ended September 30, 2017 follows:

 

Expected price volatility

   78.39%

Risk-free interest rate

   1.92%

Weighted average expected life in years

   6 years

Dividend yield

   —  
Summary of Warrant Activity

Warrant activity during the nine months ended September 30, 2017 was as follows:

 

     Number of
Shares
     Weighted
Average
Exercise
Price
Per Share
     Aggregate
Intrinsic
Value
 

Outstanding at January 1, 2017

     84,986      $ 3.53     

Granted in 2017

     1,701,583        2.38     

Exercised

     —          —       

Forfeitures

     —          —       
  

 

 

    

 

 

    

Outstanding at September 30, 2017

     1,786,569      $ 2.43      $ 970